ERT Named Finalist for Innovative Healthcare Technology of the Year Award

Share Article

Insights Cloud™ recognized for reducing trial risk and accelerating drug development

News Image
“By enabling greater collaboration between sponsors and CROs, Insights Cloud uniquely reduces clinical trial risk and accelerates the development process” said Peg Regan, Vice President, eClinical Insights at ERT.

July 27, 2016 (PRWEB) July 27, 2016 -- ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today announced that Insights Cloud has been named a finalist for the Innovative Healthcare Technology of the Year award by the Massachusetts Technology Leadership Council (MassTLC).

Insights Cloud is a cloud-based clinical trial oversight and collaboration solution that simplifies the increasingly complex relationships between clinical trial sponsors and clinical research organizations (CROs). By integrating disparate data sources in real-time, sponsors and CROs achieve the transparency, flexibility and accountability needed to help them meet their individual and shared goals.

“By enabling greater collaboration between sponsors and CROs, Insights Cloud uniquely reduces clinical trial risk and accelerates the development process,” said Peg Regan, Vice President, eClinical Insights at ERT. “We are honored that MassTLC recognizes the value of Insights Cloud, and are delighted to be considered a finalist for the Innovative Healthcare Technology of the Year Award.”

The Mass TLC Innovative Healthcare Technology of the Year Award recognizes an innovative technology that has had a significant impact in the category of healthcare (i.e., delivery of care, patient engagement, medical research). Insights Cloud was selected as one of five finalists from hundreds nominated, as judged by a panel of industry leaders.

“Congratulations to ERT on being named a finalist in the 2016 MassTLC Leadership Awards,” said MassTLC CEO Tom Hopcroft. “The finalists this year all exemplify the innovative, can-do spirt that has made Massachusetts a global leader for the past three centuries. We applaud ERT for their contribution to the Massachusetts ecosystem.”

For additional information, visit http://www.ert.com/insights-cloud.

About ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process. ERT delivers widely deployed solutions in centralized Cardiac Safety, Respiratory, and electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. For more information see http://www.ert.com. Join ERT on LinkedIn, Twitter, YouTube and Facebook.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Christine Tobin
ERT
+1 (412) 719-4568
Email >
Visit website